drugset / Trial / NCT00406887

Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis

NCT00406887

Phase 3 Completed 140 enrolled Sirion Therapeutics, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this phase 3 confirmatory study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of treatment of uveitis.

Timeline

Start
2002-08
Primary completion
Completion
2003-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Difluprednate Small molecule 0.05 %